Centene is trading at $65.59, down 4.18%, with no clear new company-specific catalyst for the November 2 decline in available reporting. - Truist raised its price target to $82 from $80 and maintained a Buy rating; the positive update does not explain the drop. - Centene’s planned Hawaii Medicaid exit affects about 24,000 members, but was reported earlier and is not established as the cause of the move. - Major indexes were higher, so broad-market weakness does not explain the decline.